SCARSI, Mirko
 Distribuzione geografica
Continente #
EU - Europa 2.437
NA - Nord America 1.865
AS - Asia 863
SA - Sud America 119
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 30
OC - Oceania 2
Totale 5.389
Nazione #
US - Stati Uniti d'America 1.820
IT - Italia 1.638
CN - Cina 307
SG - Singapore 306
DE - Germania 207
UA - Ucraina 163
FR - Francia 106
BR - Brasile 104
HK - Hong Kong 81
FI - Finlandia 80
GB - Regno Unito 70
RU - Federazione Russa 48
VN - Vietnam 48
TR - Turchia 33
IN - India 30
CA - Canada 29
IE - Irlanda 26
SE - Svezia 20
NL - Olanda 18
BD - Bangladesh 14
ZA - Sudafrica 13
ES - Italia 12
MX - Messico 11
IQ - Iraq 10
JP - Giappone 9
PL - Polonia 8
CH - Svizzera 7
AR - Argentina 6
AT - Austria 6
NG - Nigeria 6
EU - Europa 4
NP - Nepal 4
RO - Romania 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
JO - Giordania 3
MA - Marocco 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CO - Colombia 2
ID - Indonesia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.320
Città #
Singapore 177
Ashburn 171
Fairfield 128
Jacksonville 119
Milan 119
Woodbridge 115
Rome 114
Ann Arbor 105
Beijing 104
San Jose 86
Hong Kong 81
Houston 71
Chandler 61
Wilmington 58
The Dalles 54
Seattle 53
Helsinki 52
New York 52
Cambridge 50
Princeton 50
Nanjing 40
Turin 40
Los Angeles 39
Bologna 35
Munich 34
Dallas 32
Brescia 28
Istanbul 26
Dublin 25
Lauterbourg 25
Florence 22
Columbus 20
Council Bluffs 17
Des Moines 17
Ho Chi Minh City 17
Nanchang 17
Orem 17
Moscow 16
Mumbai 14
Verona 14
Dearborn 13
Genoa 13
Padova 13
Buffalo 12
Modena 12
São Paulo 12
Torino 12
Montreal 11
Trieste 11
Santa Clara 10
Sassari 10
Venice 10
Changsha 9
Hanoi 9
Hebei 9
Johannesburg 9
Naples 9
San Francisco 9
Shanghai 9
Shenyang 9
Brooklyn 8
Reggio Nell'emilia 8
Tianjin 8
Tokyo 8
Bari 7
Boardman 7
Jinan 7
Palermo 7
Redondo Beach 7
Trento 7
Turku 7
Chennai 6
Genova 6
Jiaxing 6
London 6
Manchester 6
Messina 6
Nürnberg 6
Perugia 6
Poplar 6
San Diego 6
Stockholm 6
Warsaw 6
Abuja 5
Ankara 5
Bergamo 5
Chicago 5
Duino-Aurisina 5
Ferrara 5
Frankfurt am Main 5
Hangzhou 5
Lanzhou 5
Vancouver 5
Vienna 5
Amsterdam 4
Atlanta 4
Baghdad 4
Belo Horizonte 4
Capua 4
Castelnuovo Rangone 4
Totale 2.758
Nome #
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.856
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 205
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 188
Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases. 172
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 168
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 155
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 153
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 152
Impact of in utero environment on the offspring of lupus patients 150
LA PREDITTIVITA DEGLI ANTICORPI ANTI-RO/SSA-P200 NEL BLOCCO CARDIACO CONGENITO 149
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 141
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 139
Type I interferons in systemic autoimmunity. 135
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 135
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 135
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 127
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 119
REDUCTION OF PERIPHERAL BLOOD G-IFN AND IL-17 PRODUCING T CELLS AFTER THERAPY WITH ABATACEPT FOR RHEUMATOID ARTHRITIS 118
Pregnancy in systemic sclerosis: a prospective study 116
THE EFFECTS ON T-CELL IMMUNE PHENOTYPE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH TWO DIFFERENT REGIMENS OF VITAMIN D SUPPLEMENTATION 116
WINTER LUPUS FLARES ARE ASSOCIATED WITH LOWER VITAMIN D LEVELS IN A RETROSPECTIVE LONGITUDINAL STUDY OF ITALIAN PATIENTS 114
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 114
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 97
REDUCTION OF T-CELL CLONAL EXPANSION IN RHEUMATOID ARTHRITIS PATIENTS AFTER 12 MONTHS OF ABATACEPT TREATMENT. 97
LOW NUMBERS OF CIRCULATING CD28 NEGATIVE T CELLS MAY BE A PREDICTIVE FACTOR OF A GOOD CLINICAL RESPONSE TO ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS 91
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 87
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 84
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial 76
Totale 5.389
Categoria #
all - tutte 19.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022462 0 47 13 40 20 63 40 44 34 52 48 61
2022/2023397 46 10 16 24 38 68 13 37 68 16 35 26
2023/2024344 21 9 25 36 21 58 16 23 55 7 29 44
2024/2025726 45 21 9 79 88 100 60 53 58 30 115 68
2025/20261.179 134 140 77 178 166 118 151 41 50 65 36 23
2026/202770 38 32 0 0 0 0 0 0 0 0 0 0
Totale 5.389